Isavuconazole activity against emerging fungal pathogens with reduced azole-susceptibility: Aspergillus lentulus, Neosartorya udagawae and Cryptococcus gattii | ||
| dc.conicet.organizacion | University Johns Hopkins | |
| dc.conicet.organizacion | University Johns Hopkins | |
| dc.conicet.organizacion | University Johns Hopkins | |
| dc.conicet.organizacion | Universidad Nacional del Litoral. Facultad de Bioquímica y Ciencias Biológicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Santa Fe | |
| dc.conicet.organizacion | University of Medicine and Dentistry of New Jersey. New Jersey Medical School. Public Health Research Institute Center | |
| dc.conicet.organizacion | University Johns Hopkins | |
| dc.conicet.organizacion | University Johns Hopkins | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.paisOrganizacion | Estados Unidos | |
| dc.conicet.produccionid | 2782820 | |
| dc.contributor.author | Datta, K. | |
| dc.contributor.author | Rhee, P. | |
| dc.contributor.author | Byrnes III, E. | |
| dc.contributor.author | Garcia, Guillermo Manuel | |
| dc.contributor.author | Perlin, D. S. | |
| dc.contributor.author | Staab, J. F. | |
| dc.contributor.author | Marr, K. A. | |
| dc.date.accessioned | 2016-07-14T20:52:00Z | |
| dc.date.available | 2016-07-14T20:52:00Z | |
| dc.date.issued | 2013-06 | |
| dc.date.updated | 2016-07-06T15:45:38Z | |
| dc.description.abstract | Isavuconazole is an extended-spectrum triazole with in vitro activity against a wide variety of fungal pathogens. Clinical isolates of molds Aspergillus lentulus and Neosartorya udagawae and yeast Cryptococcus gattii VGII (implicated in the outbreak in the Pacific Northwest, North America) exhibit reduced susceptibilities to several azoles but higher susceptibilities to isavuconazole. | es |
| dc.description.fil | Fil: Datta, K.. University Johns Hopkins; Estados Unidos | |
| dc.description.fil | Fil: Rhee, P.. University Johns Hopkins; Estados Unidos | |
| dc.description.fil | Fil: Byrnes III, E.. University Johns Hopkins; Estados Unidos | |
| dc.description.fil | Fil: Garcia, Guillermo Manuel. Universidad Nacional del Litoral. Facultad de Bioquímica y Ciencias Biológicas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Santa Fe; Argentina | |
| dc.description.fil | Fil: Perlin, D. S.. University of Medicine and Dentistry of New Jersey. New Jersey Medical School. Public Health Research Institute Center; Estados Unidos | |
| dc.description.fil | Fil: Staab, J. F.. University Johns Hopkins; Estados Unidos | |
| dc.description.fil | Fil: Marr, K. A.. University Johns Hopkins; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Datta, K.; Rhee, P.; Byrnes III, E.; Garcia, Guillermo Manuel; Perlin, D. S.; et al.; Isavuconazole activity against emerging fungal pathogens with reduced azole-susceptibility: Aspergillus lentulus, Neosartorya udagawae and Cryptococcus gattii; American Society For Microbiology; Journal of Clinical Microbiology; 51; 9; 6-2013; 3090-3093 | es |
| dc.identifier.issn | 0095-1137 | |
| dc.identifier.uri | http://hdl.handle.net/11336/6512 | |
| dc.journal.ciudad | Washington | es |
| dc.journal.number | 9 | es |
| dc.journal.pagination | 3090-3093 | es |
| dc.journal.pais | Estados Unidos | es |
| dc.journal.title | Journal of Clinical Microbiology | es |
| dc.journal.volume | 51 | es |
| dc.language.iso | eng | es |
| dc.publisher | American Society For Microbiology | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/10.1128/JCM.01190-13 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://jcm.asm.org/content/51/9/3090 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | es |
| dc.subject | Isovuconazol | es |
| dc.subject | Susceptibility | es |
| dc.subject | Aspergillus Lentulus | es |
| dc.subject | Cryptococcus Gatti | es |
| dc.subject.classification | Enfermedades Infecciosas | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Isavuconazole activity against emerging fungal pathogens with reduced azole-susceptibility: Aspergillus lentulus, Neosartorya udagawae and Cryptococcus gattii | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.8718_A.pdf
- Tamaño:
- 199.75 KB
- Formato:
- Adobe Portable Document Format